Literature DB >> 11562435

Effects on gamma-aminobutyric acid (GABA)(A) receptors of a neuroactive steroid that negatively modulates glutamate neurotransmission and augments GABA neurotransmission.

S Mennerick1, C M Zeng, A Benz, W Shen, Y Izumi, A S Evers, D F Covey, C F Zorumski.   

Abstract

Neurosteroids positively and negatively modulate gamma-aminobutyric acid (GABA)(A) receptors and glutamate receptors, which underlie most fast inhibition and excitation in the central nervous system. We report the identification of a neuroactive steroid, (3 alpha,5 beta)-20-oxo-pregnane-3-carboxylic acid (3 alpha 5 beta PC), with unique cellular actions. 3 alpha 5 beta PC positively modulates GABA(A) receptor function and negatively modulates N-methyl-D-aspartate (NMDA) receptor function, a combination that may be of particular clinical benefit. 3 alpha 5 beta PC promotes net GABA(A) potentiation at low steroid concentrations (<10 microM) and at negative membrane potentials. At higher concentrations, the steroid also blocks GABA receptors. Because this block would presumably counteract the NMDA receptor blocking actions of 3 alpha 5 beta PC, we characterize the GABA receptor block in some detail. Agonist concentration, depolarization, and high extracellular pH increase the block. The apparent pK for both potentiation and block was 6.4 to 6.9, substantially higher than expected from carboxylated steroid in an aqueous environment. Block is not dependent on the stereochemistry of the carboxylic acid at carbon 3 and is relatively insensitive to placement of the carboxylic acid at the opposite end of the steroid (carbon 24). Potentiation is critically dependent on the stereochemistry of the carboxylic acid group at carbon 3. Consistent with the pH dependence of potentiation, effects of the amide derivative (3 alpha,5 beta)-20-oxo-pregnane-3-carboxamide, suggest that the un-ionized form of 3 alpha 5 beta PC is important for potentiation, whereas the ionized form is probably responsible for block. Further refinement of the neuroactive steroid to promote GABA potentiation and NMDA receptor block and diminish GABA receptor block may lead to a clinically useful neuroactive steroid.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11562435

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  17 in total

1.  3beta -hydroxypregnane steroids are pregnenolone sulfate-like GABA(A) receptor antagonists.

Authors:  Mingde Wang; Yejun He; Lawrence N Eisenman; Christopher Fields; Chun-Min Zeng; Jose Mathews; Ann Benz; Tao Fu; Erik Zorumski; Joe Henry Steinbach; Douglas F Covey; Charles F Zorumski; Steven Mennerick
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

2.  Activation-dependent properties of pregnenolone sulfate inhibition of GABAA receptor-mediated current.

Authors:  Lawrence N Eisenman; Yejun He; Christopher Fields; Charles F Zorumski; Steven Mennerick
Journal:  J Physiol       Date:  2003-08-01       Impact factor: 5.182

3.  Olfactory Hallucinations without Clinical Motor Activity: A Comparison of Unirhinal with Birhinal Phantosmia.

Authors:  Robert I Henkin; Samuel J Potolicchio; Lucien M Levy
Journal:  Brain Sci       Date:  2013-11-15

4.  Effects on membrane capacitance of steroids with antagonist properties at GABAA receptors.

Authors:  Steven Mennerick; Michael Lamberta; Hong-Jin Shu; Joshua Hogins; Cunde Wang; Douglas F Covey; Lawrence N Eisenman; Charles F Zorumski
Journal:  Biophys J       Date:  2008-03-13       Impact factor: 4.033

5.  Mutations of the GABA-A receptor alpha1 subunit M1 domain reveal unexpected complexity for modulation by neuroactive steroids.

Authors:  Gustav Akk; Ping Li; John Bracamontes; David E Reichert; Douglas F Covey; Joe Henry Steinbach
Journal:  Mol Pharmacol       Date:  2008-06-10       Impact factor: 4.436

6.  Kinetic analysis of voltage-dependent potentiation and block of the glycine alpha 3 receptor by a neuroactive steroid analogue.

Authors:  Xiaochun Jin; Douglas F Covey; Joe Henry Steinbach
Journal:  J Physiol       Date:  2009-01-05       Impact factor: 5.182

7.  Effects of pregnanolone alone and in combination with other positive GABAA modulators on complex behavior in rats.

Authors:  Lisa R Gerak; Michael W Stevenson; Peter J Winsauer; Joseph M Moerschbaecher
Journal:  Psychopharmacology (Berl)       Date:  2004-01-22       Impact factor: 4.530

Review 8.  Mechanisms of neurosteroid interactions with GABA(A) receptors.

Authors:  Gustav Akk; Douglas F Covey; Alex S Evers; Joe Henry Steinbach; Charles F Zorumski; Steven Mennerick
Journal:  Pharmacol Ther       Date:  2007-04-20       Impact factor: 12.310

9.  Visualizing pregnenolone sulfate-like modulators of NMDA receptor function reveals intracellular and plasma-membrane localization.

Authors:  Mariangela Chisari; Timothy J Wilding; Samuel Brunwasser; Kathiresan Krishnan; Mingxing Qian; Ann Benz; James E Huettner; Charles F Zorumski; Douglas F Covey; Steven Mennerick
Journal:  Neuropharmacology       Date:  2018-10-15       Impact factor: 5.250

Review 10.  Neurosteroids, stress and depression: potential therapeutic opportunities.

Authors:  Charles F Zorumski; Steven M Paul; Yukitoshi Izumi; Douglas F Covey; Steven Mennerick
Journal:  Neurosci Biobehav Rev       Date:  2012-10-17       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.